Screening for Latent Infections Among Users of High-Risk Immunosuppressants: A Cross-Sectional Analysis From the Veterans Health Administration Healthcare System
Schmajuk G, Montgomery A, Tarasovsky G, Li J, Hauser R, Rozenberg-Ben-Dror K, Whooley M. Screening for Latent Infections Among Users of High-Risk Immunosuppressants: A Cross-Sectional Analysis From the Veterans Health Administration Healthcare System. Journal Of Patient Safety 2022, 19: 1-7. PMID: 36395779, DOI: 10.1097/pts.0000000000001079.Peer-Reviewed Original ResearchMeSH KeywordsAntirheumatic AgentsCross-Sectional StudiesDelivery of Health CareHepatitis CHumansImmunosuppressive AgentsLatent InfectionUnited StatesUnited States Department of Veterans AffairsVeterans HealthConceptsHigher screening ratesVeterans Health AdministrationScreening ratesCross-sectional analysisHepatitis B virusHepatitis C virusLatent hepatitis B virusVeterans Affairs (VA) Corporate Data WarehouseElectronic health record-based toolsVeterans Health Administration healthcare systemNational Veterans Health AdministrationCross-sectional analysis of veteransLow-performing facilitiesGuideline-recommended screeningFacility-level factorsB/ts-DMARDsMixed-effects multivariable logistic regression modelAnalysis of veteransCorporate Data WarehouseMultivariate logistic regression modelHigher-volume facilitiesBlack/African American patientsLogistic regression modelsSynthetic disease-modifying antirheumatic drugsTargeted synthetic disease-modifying antirheumatic drugs